Firms Spar Over Hepatitis Drug

Thursday, September 5, 2013 - 20:30 in Health & Medicine

Patents: Merck & Co., too, claims a stake in hepatitis C drug from Gilead

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net